Research Analysts’ Weekly Ratings Updates for Oscar Health (OSCR)

Several brokerages have updated their recommendations and price targets on shares of Oscar Health (NYSE: OSCR) in the last few weeks:

• 5/9/2026 – Oscar Health was upgraded by Wall Street Zen from “hold” to “strong-buy”.
• 5/7/2026 – Oscar Health had its price target raised by UBS Group AG from $15.00 to $20.00. They now have a “neutral” rating on the stock.
• 5/7/2026 – Oscar Health had its price target raised by Barclays PLC from $18.00 to $21.00. They now have an “equal weight” rating on the stock.
• 5/7/2026 – Oscar Health was upgraded by Zacks Research from “hold” to “strong-buy”.
• 5/7/2026 – Oscar Health had its price target raised by Robert W. Baird from $15.00 to $19.00. They now have a “neutral” rating on the stock.
• 5/5/2026 – Oscar Health is now covered by Wolfe Research. They set a “peer perform” rating on the stock.
• 4/21/2026 – Oscar Health had its “sell (d)” rating reaffirmed by Weiss Ratings.
• 4/20/2026 – Oscar Health was upgraded by Jefferies Financial Group Inc. from “underperform” to “hold”. They now have a $16.00 price target on the stock, up from $10.00.

Insider Buying and Selling at Oscar Health

In related news, CEO Mark T. Bertolini bought 1,000,000 shares of the business’s stock in a transaction that occurred on Monday, April 6th. The stock was purchased at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Richard Scott Blackley sold 100,000 shares of the company’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer owned 1,216,660 shares of the company’s stock, valued at approximately $28,177,845.60. The trade was a 7.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 24.39% of the stock is owned by corporate insiders.

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.